Visual Acuity

Patients with advanced retinitis pigmentosa who received intravitreal optogenetics gene therapy in a phase 1/2a study experienced improved visual acuity from baseline at 16 weeks, according to a speaker.

A phase 1b/2 open-label clinical trial of patients with choroidal melanoma treated with AU-011 showed a statistically significant reduction in tumor growth rate and favorable preliminary vision, according to a speaker.

In this Healio Video Perspective from the virtual Eyecelerator conference, Ben Bergo, president and CEO, Visus Therapeutics, outlines the mechanism and clinical data of Brimochol, the company’s lead presbyopia-correcting eye drop candidate.

Results from a phase 2b study of a pilocarpine and oxymetazoline combined topical eye drop for the treatment of presbyopia significantly improved uncorrected near visual acuity.

The Artis Symbiose IOL provides sharp, continuous vision at all distances with fast adaptation, according to one specialist.

A local approach for the treatment of unilateral or asymmetric uveitis and systemic therapy for bilateral uveitis are effective guidelines, but they can be interchangeable for certain patients, according to a speaker.

Eyes co-implanted with capsular tension rings during IOL surgery showed no visual or refractive improvements over eyes undergoing IOL surgery without capsular tension ring implantation, according to a speaker.

Novartis plans further clinical development of UNR844, a topical ophthalmic solution for treating presbyopia, based on results of phase 1 and 2 studies, according to a presenter here at the American Academy of Optometry virtual meeting.

Phototherapeutic keratectomy offers fast recovery, provides symptomatic relief and can improve visual acuity in post-traumatic corneas, according to a speaker.

Patients with neovascular age-related macular degeneration who have a 3 month or longer lapse of anti-VEGF treatment may experience unrecoverable loss of vision, according to a study.